Chronic pain
Osteoarthritis is a leading cause of chronic pain occurring in about one-third of the over 60-year-old.
It makes joints damaged with various causes, accompanied by pains around the joints.
iNT, with a sole intention to create a healthier society,
are in a tireless pursuit of developing the first-in-class drugs with a novel mechanism targeting ion channels
for patients suffering from intractable neurological diseases worldwide.
Research on intractable disease grounded on
iNT’s innovative ion-channel based platformChronic pain
Osteoarthritis is a leading cause of chronic pain occurring in about one-third of the over 60-year-old.
It makes joints damaged with various causes, accompanied by pains around the joints.
Hearing loss
Hearing Loss is caused by multiple reasons including genetic and
environment and is known to be caused mainly by inner ear hair cell death.Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis which is also known as Lou Gehrig’s disease is refractory disease caused
by specific degeneration of motoneuron specific degeneration over time and inducing respiratory problem, having high mortality.Epilepsy
It is a symptom caused by temporary and irregular erethism hyperexcitabilities of neurons,
and temporal lobe epilepsy is mainly found in adults.01
One-Stop assessment platform
specific to ion channel research based on patch clamp
02
Small molecule synthesis techniques
specialized in ion channel targets
03
INT’s innovative ion channel platform VITVOTM
beyond the industrial excellenceOur PIPELINE includes various therapeutic
for the treatment of neurological diseases,
based on medicinal chemical synthesis technology considering properties of ion channel targets
in medicinal chemistry and ion channel research platform.
interaputics PRESS board
interaputics PRESS board
interaputics PRESS board (NOTICE)
interaputics IR board
interaputics IR board
interaputics IR board (NOTICE)
interaputics IR board
New notice 3
New notice
New notice 4
New notice
New notice 5
New notice
New notice 6
New notice
New notice 7
New notice
New notice 8
New notice
New notice 9
New notice
New notice 10
New notice